Aflibercept in persistent neovascular AMD: comparison of different treatment strategies in switching therapy.
about
Switching to aflibercept among patients with treatment-resistant neovascular age-related macular degeneration: a systematic review with meta-analysis.Aflibercept in persistent neovascular AMD: comparison of different treatment strategies in switching therapy.Two-year outcome of treat-and-extend aflibercept after ranibizumab in age-related macular degeneration and polypoidal choroidal vasculopathy patients
P2860
Aflibercept in persistent neovascular AMD: comparison of different treatment strategies in switching therapy.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Aflibercept in persistent neov ...... rategies in switching therapy.
@en
type
label
Aflibercept in persistent neov ...... rategies in switching therapy.
@en
prefLabel
Aflibercept in persistent neov ...... rategies in switching therapy.
@en
P2093
P2860
P356
P1433
P1476
Aflibercept in persistent neov ...... rategies in switching therapy.
@en
P2093
F Missiroli
M Parravano
M Sciamanna
M Tedeschi
P2860
P2888
P304
P356
10.1038/EYE.2016.95
P577
2016-05-27T00:00:00Z
P6179
1048677296